Skip to content
Loading…
A new kind of antibody drug that more efficiently enters the brain could slow the progression of Alzheimer's disease with a much lower risk of dangerous side effects than existing therapies
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on New Scientist.